Showing results (131-140 of 721) with videos related to

Sort By:
Pageof 73
The Canadian Journal of Urology|April 23, 2018
The disappearing PI-RADS 5 prostate lesionVikram K Sabarwal, Cayde Ritchie, Kareem Rayn, et al.
Urologic Oncology|June 22, 2015
Imaging of renal cell carcinomaSandeep Sankineni, Anna Brown, Matthaeus Cieciera, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Nanoparticles in sentinel lymph node mappingGregory Ravizzini, Baris Turkbey, Tristan Barrett, et al.
AJR. American Journal of Roentgenology|July 22, 2009
Imaging of tumor angiogenesis: functional or targeted?Baris Turkbey, Hisataka Kobayashi, Mikako Ogawa, et al.
Current Opinion in Urology|November 1, 2023
AI-powered radiomics: revolutionizing detection of urologic malignanciesDavid G Gelikman, Soroush Rais-Bahrami, Peter A Pinto, et al.
AJR. American Journal of Roentgenology|August 20, 2020
PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative ReviewIvo G Schoots, Jelle O Barentsz, Leonardo K Bittencourt, et al.
Magnetic Resonance in Medicine|December 20, 2008
A Bayesian hierarchical model for the analysis of a longitudinal dynamic contrast-enhanced MRI oncology studyVolker J Schmid, Brandon Whitcher, Anwar R Padhani, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 19, 2009
Diffusion-weighted MR imaging of female pelvic tumors: a pictorial reviewCharlotte S Whittaker, Andy Coady, Linda Culver, et al.
European Urology|September 21, 2020
Measuring the Quality of Diagnostic Prostate Magnetic Resonance Imaging: A Urologist's PerspectiveGianluca Giannarini, Claudio Valotto, Rossano Girometti, et al.
IEEE Transactions on Medical Imaging|December 16, 2006
Bayesian methods for pharmacokinetic models in dynamic contrast-enhanced magnetic resonance imagingVolker J Schmid, Brandon Whitcher, Anwar R Padhani, et al.
Pageof 73